KALARIS THERAPEUTICS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
KALARIS THERAPEUTICS, INC. (KLRS) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$206.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2025-03-07
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-12-31 was -$53.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-09-30 was -$43.00K, a 133.59% decline year-over-year.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-06-30 was -$84.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-03-31 was -$26.00K, a 129.89% decline year-over-year.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was -$206.00K, a 520.41% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2023 was $49.00K, a 54.21% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2022 was $107.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2021 was -$400.00K, a 312.77% decline from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$96.00K derived: sum of 2 quarters · filed 2025-03-07 | -$180.00K derived: sum of 3 quarters · filed 2025-03-07 | -$206.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$127.00K derived: sum of 2 quarters · filed 2024-11-12 | -$153.00K 10-Q · filed 2024-11-12 | -$181.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2024-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$110.00K 10-Q · filed 2024-08-09 | -$138.00K derived: sum of 3 quarters · filed 2025-03-07 | -$10.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2024-03-31 | -$26.00K 10-Q · filed 2024-05-13 | -$54.00K derived: sum of 2 quarters · filed 2025-03-07 | $74.00K derived: sum of 3 quarters · filed 2025-03-07 | -$64.00K derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $100.00K derived: sum of 2 quarters · filed 2025-03-07 | -$38.00K derived: sum of 3 quarters · filed 2025-03-07 | $49.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.00K derived: sum of 2 quarters · filed 2024-11-12 | $77.00K 10-Q · filed 2024-11-12 | -$27.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$51.00K 10-Q · filed 2024-08-09 | -$155.00K derived: sum of 3 quarters · filed 2024-08-09 | $15.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $87.00K 10-Q · filed 2024-05-13 | -$17.00K derived: sum of 2 quarters · filed 2024-05-13 | $153.00K derived: sum of 3 quarters · filed 2024-05-13 | $72.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $66.00K derived: sum of 2 quarters · filed 2024-03-15 | -$15.00K derived: sum of 3 quarters · filed 2024-03-15 | $107.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $89.00K derived: sum of 2 quarters · filed 2023-11-02 | $211.00K 10-Q · filed 2023-11-02 | $110.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $41.00K 10-Q · filed 2023-08-03 | -$60.00K derived: sum of 3 quarters · filed 2023-08-03 | -$318.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $122.00K 10-Q · filed 2023-05-04 | $21.00K derived: sum of 2 quarters · filed 2023-05-04 | -$237.00K derived: sum of 3 quarters · filed 2023-05-04 | -$297.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$359.00K derived: sum of 2 quarters · filed 2023-02-15 | -$419.00K derived: sum of 3 quarters · filed 2023-02-15 | -$400.00K 10-K · filed 2023-02-15 |
| 2021-09-30 | -$258.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$318.00K derived: sum of 2 quarters · filed 2022-11-03 | -$299.00K 10-Q · filed 2022-11-03 | -$271.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$41.00K 10-Q · filed 2022-08-04 | -$13.00K derived: sum of 3 quarters · filed 2022-08-04 | $351.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $19.00K 10-Q · filed 2022-05-05 | $47.00K derived: sum of 2 quarters · filed 2022-05-05 | $411.00K derived: sum of 3 quarters · filed 2022-05-05 | $158.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | $392.00K derived: sum of 2 quarters · filed 2022-02-10 | $139.00K derived: sum of 3 quarters · filed 2022-02-10 | $188.00K 10-K · filed 2022-02-10 |
| 2020-09-30 | $364.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $111.00K derived: sum of 2 quarters · filed 2021-11-05 | $160.00K 10-Q · filed 2021-11-05 | $117.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | -$253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$204.00K 10-Q · filed 2021-08-06 | -$247.00K derived: sum of 3 quarters · filed 2021-08-06 | -$196.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $49.00K 10-Q · filed 2021-05-06 | $6.00K derived: sum of 2 quarters · filed 2021-05-06 | $57.00K derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $8.00K derived: sum of 2 quarters · filed 2021-02-12 | $262.00K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $305.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $254.00K 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |